BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 17177966)

  • 41. Demonstration of autoantibody binding to muscarinic acetylcholine receptors in the salivary gland in primary Sjögren's syndrome.
    Kovács L; Fehér E; Bodnár I; Marczinovits I; Nagy GM; Somos J; Boda V
    Clin Immunol; 2008 Aug; 128(2):269-76. PubMed ID: 18508410
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phosphorylated and nonphosphorylated epitopes of the La/SSB autoantigen: comparison of their antigenic and conformational characteristics.
    Coudevylle N; Rokas D; Sakarellos-Daitsiotis M; Krikorian D; Panou-Pomonis E; Sakarellos C; Boussard G; Cung MT
    Biopolymers; 2006; 84(4):368-82. PubMed ID: 16453388
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mechanisms of autoantibody production and the relationship between autoantibodies and the clinical manifestations in Sjögren's syndrome.
    Nakamura H; Kawakami A; Eguchi K
    Transl Res; 2006 Dec; 148(6):281-8. PubMed ID: 17162248
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular characterization of a major autoantibody-associated cross-reactive idiotype in Sjogren's syndrome.
    Kipps TJ; Tomhave E; Chen PP; Fox RI
    J Immunol; 1989 Jun; 142(12):4261-8. PubMed ID: 2542406
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The minor salivary gland proteome in Sjögren's syndrome.
    Hjelmervik TO; Jonsson R; Bolstad AI
    Oral Dis; 2009 Jul; 15(5):342-53. PubMed ID: 19364392
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cellular microRNAs (miRNAs) and Sjögren's syndrome: candidate regulators of autoimmune response and autoantigen expression.
    Kapsogeorgou EK; Gourzi VC; Manoussakis MN; Moutsopoulos HM; Tzioufas AG
    J Autoimmun; 2011 Sep; 37(2):129-35. PubMed ID: 21632209
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Discerning the kinetics of autoimmune manifestations in a model of Sjögren's syndrome.
    Karnell JL; Mahmoud TI; Herbst R; Ettinger R
    Mol Immunol; 2014 Dec; 62(2):277-82. PubMed ID: 24907930
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Different stages of primary Sjogren's syndrome involving lymphotoxin and type 1 IFN.
    Shen L; Suresh L; Malyavantham K; Kowal P; Xuan J; Lindemann MJ; Ambrus JL
    J Immunol; 2013 Jul; 191(2):608-13. PubMed ID: 23772034
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Autoantigens and Sjögren syndrome.
    Toda I
    Cornea; 2002 Mar; 21(2 Suppl 1):S13-6. PubMed ID: 11995803
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ro52- and Ro60-specific B cell pattern in the salivary glands of patients with primary Sjögren's syndrome.
    Aqrawi LA; Skarstein K; Øijordsbakken G; Brokstad KA
    Clin Exp Immunol; 2013 May; 172(2):228-37. PubMed ID: 23574319
    [TBL] [Abstract][Full Text] [Related]  

  • 51. LAMP3 induces apoptosis and autoantigen release in Sjögren's syndrome patients.
    Tanaka T; Warner BM; Odani T; Ji Y; Mo YQ; Nakamura H; Jang SI; Yin H; Michael DG; Hirata N; Suizu F; Ishigaki S; Oliveira FR; Motta ACF; Ribeiro-Silva A; Rocha EM; Atsumi T; Noguchi M; Chiorini JA
    Sci Rep; 2020 Sep; 10(1):15169. PubMed ID: 32939030
    [TBL] [Abstract][Full Text] [Related]  

  • 52. PUF60: a prominent new target of the autoimmune response in dermatomyositis and Sjögren's syndrome.
    Fiorentino DF; Presby M; Baer AN; Petri M; Rieger KE; Soloski M; Rosen A; Mammen AL; Christopher-Stine L; Casciola-Rosen L
    Ann Rheum Dis; 2016 Jun; 75(6):1145-51. PubMed ID: 26253095
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Investigation of autoantibodies to SP-1 in Chinese patients with primary Sjögren's syndrome.
    Xuan J; Wang Y; Xiong Y; Qian H; He Y; Shi G
    Clin Immunol; 2018 Mar; 188():58-63. PubMed ID: 29292085
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of salivary anti-SSA/B antibodies for diagnosing primary Sjögren's syndrome.
    Wei P; Li C; Qiang L; He J; Li Z; Hua H
    Med Oral Patol Oral Cir Bucal; 2015 Mar; 20(2):e156-60. PubMed ID: 25475778
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antigen-driven selection of antibodies against SSA, SSB and the centromere 'complex', including a novel antigen, MIS12 complex, in human salivary glands.
    Takeshita M; Suzuki K; Kaneda Y; Yamane H; Ikeura K; Sato H; Kato S; Tsunoda K; Arase H; Takeuchi T
    Ann Rheum Dis; 2020 Jan; 79(1):150-158. PubMed ID: 31611218
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Salivary anti-Ro60 and anti-Ro52 antibody profiles to diagnose Sjogren's Syndrome.
    Ching KH; Burbelo PD; Gonzalez-Begne M; Roberts ME; Coca A; Sanz I; Iadarola MJ
    J Dent Res; 2011 Apr; 90(4):445-9. PubMed ID: 21212317
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Defective selection of thymic regulatory T cells accompanies autoimmunity and pulmonary infiltrates in Tcra-deficient mice double transgenic for human La/Sjögren's syndrome-B and human La-specific TCR.
    Yaciuk JC; Pan Y; Schwarz K; Pan ZJ; Maier-Moore JS; Kosanke SD; Lawrence C; Farris AD
    J Immunol; 2015 Feb; 194(4):1514-22. PubMed ID: 25582858
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An immunodominant La/SSB autoantibody proteome derives from public clonotypes.
    Thurgood LA; Arentz G; Lindop R; Jackson MW; Whyte AF; Colella AD; Chataway TK; Gordon TP
    Clin Exp Immunol; 2013 Nov; 174(2):237-44. PubMed ID: 23841690
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ductal epithelial expression of Ro52 correlates with inflammation in salivary glands of patients with primary Sjögren's syndrome.
    Aqrawi LA; Kvarnström M; Brokstad KA; Jonsson R; Skarstein K; Wahren-Herlenius M
    Clin Exp Immunol; 2014 Jul; 177(1):244-52. PubMed ID: 24673429
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Autoantibodies from Sjögren's syndrome trigger apoptosis in salivary gland cell line.
    Sisto M; Lisi S; Lofrumento D; D'Amore M; Scagliusi P; Mitolo V
    Ann N Y Acad Sci; 2007 Jun; 1108():418-25. PubMed ID: 17894006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.